Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharid on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 20, Issue 3, 2015, Pages 289-298

  Rajkumar, Hemalatha ^a   Kumar, Manoj ^a   Das, Nilita ^a   Kumar, S Nishanth ^a   Challa, Hanumanth R ^a   Nagpal, Ravinder ^b  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

fructo oligosaccharides; inflammation; insulin resistance; Lactobacillus salivarius; prebiotics; probiotics; synbiotics

Indexed keywords

C REACTIVE PROTEIN; FRUCTOSE OLIGOSACCHARIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTOBACILLUS SALIVARIUS UBL S22; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LIPID; OLIGOSACCHARIDE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESCHERICHIA COLI; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; LIPID BLOOD LEVEL; MALE; MICROCAPSULE; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; YOUNG ADULT; BLOOD; LACTOBACILLUS; VOLUNTEER;

ADULT; C-REACTIVE PROTEIN; GASTROINTESTINAL MICROBIOME; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; LACTOBACILLUS; LIPIDS; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS; SINGLE-BLIND METHOD; TUMOR NECROSIS FACTOR-ALPHA; VOLUNTEERS;

EID: 84928230741     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248414555004     Document Type: Article

References (68)

1. Fuller R. Probiotics in human medicine. Gut. 1991 ; 32 (4). 439-442
2. Salminen SJ, Gueimonde M, Isolauri E. Probiotics that modify disease risk. J Nutr. 2005 ; 135 (5). 1294-1298
3. Nagpal R, Yadav H, Puniya AK, Singh K, Jain S, Marotta F. Potential of probiotics and prebiotics for synbiotic functional dairy foods. Int J Probiotics Prebiotics. 2007 ; 2 (2). 75-84
4. Nagpal R, Kumar A, Kumar M, Behare PV, Jain S, Yadav H. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett. 2012 ; 334 (1). 1-15
5. Kumar R, Grover S, Batish VK. Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br J Nutr. 2011 ; 105 (4). 561-573
6. Kumar M, Nagpal R, Kumar R, et al. Cholesterol lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diab Res. 2012 ; 2012: 902917
7. Kumar M, Verma V, Nagpal R, et al. Anticarcinogenic effect of probiotic fermented milk and Chlorophyllin on aflatoxin-B1 induced liver carcinogenesis in rats. Br J Nutr. 2012 ; 107 (7). 1006-1016
8. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut. 2013 ; 62 (5). 787-796
9. Hemalatha R, Mahmood N, Kumar M, Varikuti SR, Challa HR, Prakash SM. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers and gut colonization in overweight adults: a randomized, controlled trial. Mediat Inflamm. 2014 ; 2014: 348959 doi: 10.1155/2014/348959
10. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995 ; 125 (6). 1401-1412
11. Abrahamsson TR, Jakobsson T, Bottcher MF, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007 ; 119 (5). 1174-1180
12. Canani RB, Cirillo P, Terrin G, et al. Probiotics for treatment of acute diarrhea in children: randomized clinical trial of five different preparations. BMJ. 2007 ; 335 (7615). 335-340
13. Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther. 2008 ; 27 (1). 48-57
14. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006 ; 444 (7122). 1027-1031
15. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013 ; 27 (1). 73-83
16. Cani PD. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clin Microbiol Infect. 2012 ; 18(suppl 4): 50-53
17. Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol. 2013 ; 13 (6). 935-940
18. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007 ; 56 (7). 1761-1772
19. Nadhazi Z, Takats A, Offenmuller K, Bertok L. Plasma endotoxin level of healthy donors. Acta Microbiol Immunol Hung. 2002 ; 49 (1). 151-157
20. Creely SJ, McTernan PG, Kusminski CM, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007 ; 292 (3). E740 - E747
21. Ji Y, Sakata Y, Tso P. Nutrient-induced inflammation in the intestine. Curr Opin Clin Nutr. 2011 ; 14 (4). 315-321
22. Lassenius MI, Pietilainen KH, Kaartinen K, et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diab Care. 2011 ; 34 (8). 1809-1815
23. Nakarai H, Yamashita A, Nagayasu S, et al. Adopocytemacrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications. Innate Immun. 2011 ; 18 (1). 164-170
24. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007 ; 104 (3). 979-984
25. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009 ; 22 (7228). 480-484
26. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008 ; 57 (6). 1470-1481
27. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Rev Endocrinol. 2011 ; 7 (11). 639-646
28. Amar J, Chabo C, Waget A, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011 ; 3 (9). 559-572
29. Everard A, Lazarevis V, Derrien M, et al. Response of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 2011 ; 60 (11). 2775-2786
30. Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharm Therap. 2011 ; 130 (2). 202-212
31. Yan F, Polk DB. Probiotics and immune health. Curr Opin Gastroenterol. 2011 ; 27 (6). 496-501
32. Chuang L, Wu K, Pai C, et al. Heat killed cells of lactobacilli skew the immune response toward T helper 1 polarization in mouse splenocytes and dendritic cell-trated t cells. J Agric Food Chem. 2007 ; 55 (26). 1080-1086
33. Castellazzi AM, Valsecchi C, Montagna L, et al. In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I-1688, Lactobacllius salivarius I-1749, and mixture (PSMIX). Immunol Invest. 2007 ; 36 (4). 413-421
34. Diaz-Ropero MP, Martin R, Sierra S, et al. Two Lactobacllius strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol. 2007 ; 102 (2). 337-343
35. Neville BA, O'Toole PW. Probiotic properties of Lactobacillus salivarius and closely related Lactobacillus species. Future Microbiol. 2010 ; 5 (5). 759-774
36. Tinrat S, Saraya S, Traidej CM. Isolation and characterization of Lactobacillus salivarius MTC 1026 as a potential probiotic. J Gen Appl Microbiol. 2011 ; 57 (6). 365-378
37. Hsieh PS, Tsai YC, Chen YC, Teh SF, Ou CM, King VA. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter. 2012 ; 17 (6). 466-477
38. Messaoudi S, Manai M, Kergourlaya G, et al. Lactobacillus salivarius: bacteriocin and probiotic activity. Food Microbiol. 2013 ; 36 (2). 296-304
39. Wu S, Wang G, Angert ER, Wang W, Li W, Zou H. Composition, diversity, and origin of the bacterial community in grass carp intestine. PLoS One. 2012 ; 7 (2). e30440
40. Respondek F, Gerard P, Bossis M, et al. Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLOS One. 2013 ; 8 (8). e71026
41. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 ; 18 (6). 499-502
42. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentrations in man. Diabetologia. 1985 ; 28 (7). 412-419
43. Ramachandran A, Snehalatha C, Kapur A., et al. Diabetes epidemiology study group in India (DESI): High prevalence of diabetes and impaired glucose tolerance. National urban diabetes survey. Diabetologia. 2001 ; 44 (9). 1094-1101
44. Fabian E, Elmadfa I. Influence of daily consumption of probiotic conventional yogurt on plasma lipid profile in young healthy women. Annu Nutr Metabol. 2006 ; 50 (4). 387-393
45. Klein A, Friedrich U, Vogelsang H, Jahreis G. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr. 2008 ; 62 (5). 584-593
46. Mohania D, Kansal VK, Shah D, et al. Therapeutic effect of probiotic dahi on plasma, aortic, and hepatic lipid profile of hypercholesterolemic rats. J Cardiovasc Pharmacol Ther. 2013 ; 18 (5). 490-497
47. Schaafsma G, Meuling WJA, van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr. 1998 ; 52 (6). 436-440
48. Ooi LG, Ahmad R, Yuen KH, Liong MT. Lactobacillus acidophilus CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J Dairy Sci. 2010 ; 93 (11). 5048-5058
49. DiRienzo DB. Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets. Nutr Rev. 2014 ; 72 (1). 18-29
50. Carol M, Borruel N, Antolin M, et al. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease. J Leukocyte Biol. 2006 ; 79 (5). 917-922
51. Meyer AL, Elmadfa I, Herbacek I, Micksche M. Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines. J Hum Nutr Diet. 2007 ; 20 (6). 590-598
52. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D. Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol. 2012 ; 10 (1-2). 37-54
53. Bodera P, Chcialowski A. Immunomodulatory effect of probiotic bacteria. Rec Patents Inflamm Aller Drug Discov. 2009 ; 3 (1). 58-64
54. Guigoz Y, Rochat F, Perruisseau-Carrier G, Rochat I, Schiffrin E. Effects of oligosaccharide on the fecal flora and non-specific immune system in elderly people. Nutr Res. 2002 ; 22 (1-2). 13-25
55. Roller M, Rechkemmer G, Watzl B. Prebiotic inulin enriched with oligofructose in combination with the prebiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr. 2004 ; 134 (1). 153-156
56. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture in healthy elderly volunteers. Am J Clin Nutr. 2008 ; 88 (5). 1438-1446
57. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutr. 2007 ; 23 (1). 62-68
58. Yadav H, Lee JH, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced glp-1 hormone secretion. J Biol Chem. 2013 ; 288 (35). 25088-25097
59. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009 ; 58 (8). 1091-1103
60. Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009 ; 90 (5). 1236-1243
61. Childs CE, Roytio H, Alhoniemi E, et al. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomized, factorial cross-over study[published online March 24, 2014]. Br J Nutr. 2014 ;: 1-12
62. Vyas U, Ranganathan N. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract. 2012 ; 2012: 872716
63. Toh ZQ, Anzela A, Tang MLK, Licciardi PV. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol. 2012 ; 3: 171. doi: 10.3389/fphar.2012.00171
64. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp ratPrebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp ratsParnell JA, Reimer RA. Prebiotic fibers dose-dependently increase satiety hormones and alter bacteroidetes and firmicutes in lean and obese JCR: LA-cp rats. Br J Nutr. 2012 ; 107 (4). 601-613
65. Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhea. Aliment Pharmacol Ther. 2012 ; 35 (12). 1355-1369
66. Tsai YT, Cheng PC, Pan TM. Anti-obesity effects of gut microbiota are associated with lactic acid bacteria. Appl Microbiol Biotechnol. 2014 ; 98 (1). 1-10
67. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis. 2009 ; 15 (2). 300-310
68. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol. 2009 ; 9 (6). 737-743